UTHR (unither.com) Wutah bathi saben saham ing taun iki

United Therapeutics combines strategic xenotransplantation alliances with steady demand for hypertension therapy. The annual change in EPS clearly demonstrates the business's reaction to market challenges, with the indicator reaching -11.60. A commitment to ESG principles is reflected in the construction of energy-efficient, net-zero carbon laboratories.
Rincian metrik keuangan lan pasar unither.com (UTHR)
- nilai saham lan prakiraan konsensus rega:
- indikator valuasi pasar bisnis:
- informasi kapitalisasi buku:
- informasi babagan utang lan solvabilitas:
Rasio Kabeh Utang marang Dana Pribadi United Therapeutics|UTHR - Utang jangka dawa marang modal|Utang jangka cendhak marang modal United Therapeutics Corp|UTHR - Utang perusahaan|Rasio utang marang aset resik United Therapeutics Corporation|UTHR - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan United Therapeutics|Rasio cepet unither.com
- indikator pendapatan resik lan kelipatan nilai:
UTHR - Penghasilan resik|Proyeksi bathi mangsa ngarep United Therapeutics|UTHR - Rasio rega marang bathi|Rasio rega marang bathi mangsa ngarep United Therapeutics|UTHR - Pangali PEG|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan United Therapeutics Corp|UTHR - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone patang kuartal pungkasan United Therapeutics|UTHR - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan unither.com|UTHR - Wutah bathi ing taun lumaku|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep United Therapeutics
- data pendapatan lan penerimaan dodolan:
Analisis dhasar perusahaan:United Therapeutics Inc. (UTHR)

Professional managers utilize earnings per share dynamics to distinguish sustainable businesses from overvalued assets. This indicator measures the annual change in net income, reflecting the ability of United Therapeutics (UTHR) to convert its monopoly in the orphan disease niche into real growth of shareholder equity, as clearly evidenced by the year-over-year EPS growth rates.
Pesaing utama
Kacepetan wutah bathi saben saham ing taun lumaku Vertex Pharmaceuticals Inc. (VRTX)|ALNY (Alnylam) - Wutah bathi ing taun lumaku|Wutah bathi saben saham ing taun iki INSM (Insmed)|Wutah bathi resik saben saham ing taun iki BMRN (BioMarin)|BBIO (BridgeBio Pharma) - Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku BGM (BGM Group Ltd)|COGT (Cogent Bio) - Dinamika bathi saben saham ing taun lumaku|Xeris Biopharma - Wutah bathi ing taun lumaku|Tambahing bathi saben saham ing taun lumaku KROS (Keros Therapeutics)|ARCT: Wutah bathi ing taun lumaku|Eton Pharmaceuticals Inc (ETON) - Wutah bathi ing taun lumaku|Wutah bathi saben saham ing taun lumaku Kamada Corp|FULC: Tambahing bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku Abeona Therapeutics, Inc. (ABEO)|Wutah bathi resik saben saham ing taun iki Mereo BioPharma Group plc MREO|Wutah bathi saben saham ing taun lumaku Protalix BioTherapeutics PLX|Wutah bathi ing taun lumaku Pliant Therapeutics PLRX|appliedtherapeutics.com - Wutah bathi ing taun lumaku|Tambahing bathi saben saham ing taun lumaku RNTX (Rein Therapeutics, Inc.)|GELS: Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Aytu BioPharma, Inc. (AYTU)|CMMB (Chemomab Therapeutics Ltd) - Wutah bathi ing taun lumaku|Wutah bathi saben saham ing taun iki SRXH (SRx Health Solutions)|Wutah bathi resik saben saham ing taun iki PLRZ (Polyrizon Ltd)|AEZS - Kacepetan wutah bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku Cyclo Therapeutics Inc. CYTH|Inozyme Pharma, Inc. (INZY) - Kacepetan wutah bathi saben saham ing taun lumaku|RPHM: Wutah bathi resik saben saham ing taun iki|Kacepetan wutah bathi saben saham ing taun lumaku COSCIENS Biopharma Inc